These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18180978)

  • 1. Polyglandular autoimmunity with macrophagic myofasciitis.
    Theeler BJ; Simper NB; Ney JP
    Clin Rheumatol; 2008 May; 27(5):667-9. PubMed ID: 18180978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophagic myofasciitis and vaccination: consequence or coincidence?
    Santiago T; Rebelo O; Negrão L; Matos A
    Rheumatol Int; 2015 Jan; 35(1):189-92. PubMed ID: 24923906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle.
    Gherardi RK; Coquet M; Cherin P; Belec L; Moretto P; Dreyfus PA; Pellissier JF; Chariot P; Authier FJ
    Brain; 2001 Sep; 124(Pt 9):1821-31. PubMed ID: 11522584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophagic myofasciitis in children is a localized reaction to vaccination.
    Lach B; Cupler EJ
    J Child Neurol; 2008 Jun; 23(6):614-9. PubMed ID: 18281624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophagic myofasciitis: a summary of Dr. Gherardi's presentations.
    Brenner A
    Vaccine; 2002 May; 20 Suppl 3():S5-6. PubMed ID: 12184366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system.
    Gherardi RK; Crépeaux G; Authier FJ
    Autoimmun Rev; 2019 Jul; 18(7):691-705. PubMed ID: 31059838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophagic myofasciitis associated with inclusion body myositis: a report of three cases.
    Chérin P; Menard D; Mouton P; Viallard JF; Le Hello C; Authier FJ; Ghérardi RK; Coquet M; Herson S; Leroi JP
    Neuromuscul Disord; 2001 Jul; 11(5):452-7. PubMed ID: 11404116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccine adjuvants and macrophagic myofasciitis].
    Siegrist CA
    Bull Acad Natl Med; 2003; 187(8):1511-8; discussion 1519-21. PubMed ID: 15146582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophagic myofasciitis and subcutaneous pseudolymphoma caused by aluminium adjuvants.
    Kim H; Lim KY; Kang J; Park JW; Park SH
    Sci Rep; 2020 Jul; 10(1):11834. PubMed ID: 32678281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome].
    Gherardi RK
    Rev Neurol (Paris); 2003 Feb; 159(2):162-4. PubMed ID: 12660567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Public health. Aluminum is put on trial as a vaccine booster.
    Malakoff D
    Science; 2000 May; 288(5470):1323-4. PubMed ID: 10847840
    [No Abstract]   [Full Text] [Related]  

  • 12. Aluminum phagocytosis in quadriceps muscle following vaccination in children: relationship to macrophagic myofasciitis.
    Lacson AG; D'Cruz CA; Gilbert-Barness E; Sharer L; Jacinto S; Cuenca R
    Pediatr Dev Pathol; 2002; 5(2):151-8. PubMed ID: 11910509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld's syndrome): clinical and immunological spectrum.
    Vera-Lastra O; Medina G; Cruz-Dominguez Mdel P; Jara LJ; Shoenfeld Y
    Expert Rev Clin Immunol; 2013 Apr; 9(4):361-73. PubMed ID: 23557271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophagic myofasciitis in childhood: a controversial entity.
    Rivas E; Gómez-Arnáiz M; Ricoy JR; Mateos F; Simón R; García-Peñas JJ; Garcia-Silva MT; Martín E; Vázquez M; Ferreiro A; Cabello A
    Pediatr Neurol; 2005 Nov; 33(5):350-6. PubMed ID: 16243223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identical twins with macrophagic myofasciitis: genetic susceptibility and triggering by aluminic vaccine adjuvants?
    Guis S; Mattei JP; Nicoli F; Pellissier JF; Kaplanski G; Figarella-Branger D; Manez GC; Antipoff GM; Roudier J
    Arthritis Rheum; 2002 Oct; 47(5):543-5. PubMed ID: 12382305
    [No Abstract]   [Full Text] [Related]  

  • 16. Aluminum adjuvants of vaccines injected into the muscle: Normal fate, pathology and associated disease.
    Gherardi RK; Aouizerate J; Cadusseau J; Yara S; Authier FJ
    Morphologie; 2016 Jun; 100(329):85-94. PubMed ID: 26948677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophagic myofaciitis a vaccine (alum) autoimmune-related disease.
    Israeli E; Agmon-Levin N; Blank M; Shoenfeld Y
    Clin Rev Allergy Immunol; 2011 Oct; 41(2):163-8. PubMed ID: 20882368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role for the body burden of aluminium in vaccine-associated macrophagic myofasciitis and chronic fatigue syndrome.
    Exley C; Swarbrick L; Gherardi RK; Authier FJ
    Med Hypotheses; 2009 Feb; 72(2):135-9. PubMed ID: 19004564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophagic Myofasciitis.
    Stenzel W; Heppner FL; Goebel HH; Alten RH
    Dtsch Arztebl Int; 2009 Apr; 106(14):248. PubMed ID: 19547641
    [No Abstract]   [Full Text] [Related]  

  • 20. Cognitive dysfunction associated with aluminum hydroxide-induced macrophagic myofasciitis: A reappraisal of neuropsychological profile.
    Aoun Sebaiti M; Kauv P; Charles-Nelson A; Van Der Gucht A; Blanc-Durand P; Itti E; Gherardi RK; Bachoud-Levi AC; Authier FJ
    J Inorg Biochem; 2018 Apr; 181():132-138. PubMed ID: 29079320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.